Top Markets
Coin of the day
Bloomage BioTechnology Corporation Limited Bloomage BioTechnology Corporation Limited

Bloomage BioTechnology Corporation Limited

688363
Rang in Aktien #5711
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and... Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.
Aktienkurs
$5.21
Marktkapitalisierung
$2.49B
Veränderung (1 Tag)
-0.91%
Veränderung (1 Jahr)
-34.46%
Land
CN
Handel Bloomage BioTechnology Corporation Limited (688363)
Dividendenrendite-Verlauf für Bloomage BioTechnology Corporation Limited (688363)
Dividendenrendite (TTM) von Bloomage BioTechnology Corporation Limited (Aktienkürzel: 688363) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Bloomage BioTechnology Corporation Limited (688363) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber